REAL WORLD EVALUATION OF MAJOR BLEEDING RISK AND COSTS FOR ALL CAUSES AND BLEEDING-RELATED HEALTH SERVICES AMONG ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH APIXABAN OR WARFARIN

Conclusions: In the real-world setting after balancing patient characteristics, apixaban treatment is associated with significantly lower risk of major bleeding as well as significantly lower costs for all causes and bleeding-related health services among elderly NVAF patients in the US.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.312-312
Hauptverfasser: Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Cutice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy, Lin, Jay
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusions: In the real-world setting after balancing patient characteristics, apixaban treatment is associated with significantly lower risk of major bleeding as well as significantly lower costs for all causes and bleeding-related health services among elderly NVAF patients in the US.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)33701-4